Skip to Main content Skip to Navigation
Conference papers

Impact of Response in Patients (Pts) With Stem Cell Transplant (SCT)-Ineligible Newly Diagnosed Multiple Myeloma (NDMM) Treated With Continuous Lenalidomide + Low-Dose Dexamethasone (Rd) in the FIRST Trial

Abstract : no abstract
Document type :
Conference papers
Complete list of metadatas

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01228160
Contributor : Laurent Jonchère <>
Submitted on : Thursday, November 12, 2015 - 5:33:10 PM
Last modification on : Wednesday, May 16, 2018 - 11:23:52 AM

Identifiers

Citation

N. Bahlis, A. Corso, L. -O. Mügge, Z. -X. Shen, P. Desjardins, et al.. Impact of Response in Patients (Pts) With Stem Cell Transplant (SCT)-Ineligible Newly Diagnosed Multiple Myeloma (NDMM) Treated With Continuous Lenalidomide + Low-Dose Dexamethasone (Rd) in the FIRST Trial. 15th International Myeloma Workshop, Sep 2015, Rome, Italy. pp.e56, ⟨10.1016/j.clml.2015.07.196⟩. ⟨hal-01228160⟩

Share

Metrics

Record views

87